Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03635645 · ClinicalTrials.gov registry record · NA
Experimental and Clinical Studies of Retinal Stimulation
A NA study of Retinitis Pigmentosa, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03635645: Recruiting NA study of Retinitis Pigmentosa, sponsored by University of Michigan.
NCT03635645 is a NA study of Retinitis Pigmentosa that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 20 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03635645, a NA study of Retinitis Pigmentosa, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.
Primary Outcome
Compare baseline threshold with threshold of modified stimulus parameters. Threshold is measured in microCoulumbs ( the product of stimulus duration and stimulus amplitude).
Conditions Studied
Interventions
- DEVICE New visual processing unit (VPU) with asymmetric waveforms
- DEVICE New VPU with bipolar stimulation
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-10-30 |
| Est. Completion | 2023-10-30 |
| Phase | NA |
What NCT03635645 shows while recruiting
NCT03635645 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 2 interventions - of which New visual processing unit (VPU) with asymmetric waveforms is the first listed.
NCT03635645 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03635645 about?
NCT03635645 is a clinical study titled "Experimental and Clinical Studies of Retinal Stimulation". The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.
What is the current status of trial NCT03635645?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2017-10-30. Estimated completion is 2023-10-30.
What conditions does trial NCT03635645 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa.
What interventions are being tested in trial NCT03635645?
The interventions under investigation include: New visual processing unit (VPU) with asymmetric waveforms (DEVICE), New VPU with bipolar stimulation (DEVICE).
Who is sponsoring clinical trial NCT03635645?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03635645 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03635645's enrollment target sits among peer trials
20 26th of 37 higher than 11 of 37 other Retinitis Pigmentosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinitis Pigmentosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
ACTIVE NOT RECRUITING · NA
-
Prospective Natural History Study of Retinitis Pigmentosa
ACTIVE NOT RECRUITING · NA
-
Argus II/ORCAM Device Study
COMPLETED · NA
-
Object Finder for a Retinal Prosthesis
COMPLETED · NA
-
Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI